| An oncogene isolated by transfection of Kaposi s sarcoma DNA encodes a growth factor that is a member of the FGF family. | sarcoma, |
| Chromosomal localization of the hst oncogene and its co-amplification with the int.2 oncogene in a human melanoma. | skin, |
| Mitogenic and dedifferentiating effect of the K-fgf/hst oncogene on rat thyroid PC clone 3 epithelial cells. | thyroid, |
| A retrovirus carrying the K-fgf oncogene induces diffuse meningeal tumors and soft-tissue fibrosarcomas. | fibrosarcoma, |
| Transformation and amplification of the K-fgf proto-oncogene in NIH-3T3 cells, and induction of metastatic potential. | None |
| Expression of the K-fgf proto-oncogene is controlled by 3 regulatory elements which are specific for embryonal carcinoma cells. | None |
| Nucleotide sequence of the 5 -flanking region of the mouse k-FGF oncogene exhibits an alternating purine:pyrimidine motif with the potential to form Z-DNA. | None |
| Expression and developmental regulation of the k-FGF oncogene in human and murine embryonal carcinoma cells. | None |
| Transformation of NIH 3T3 cells with basic fibroblast growth factor or the hst/K-fgf oncogene causes downregulation of the fibroblast growth factor receptor: reversal of morphological transformation and restoration of receptor number by suramin. | None |
| Expression and activation of the K-fgf oncogene. | None |
| The FGF-related oncogene, K-FGF, maps to human chromosome region 11q13, possibly near int-2. | None |